Maternal serum highly sensitive C-reactive protein in normal pregnancy and pre-eclampsia.

Division of Maternal and Fetal Medicine, Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seodaemun-gu, Seoul, South Korea.
International Journal of Gynecology & Obstetrics (Impact Factor: 1.56). 09/2007; 98(2):105-9. DOI: 10.1016/j.ijgo.2007.03.050
Source: PubMed

ABSTRACT To establish reference values for highly sensitive C-reactive protein (hsCRP) in normal pregnancy and determine whether disease severity could be predicted by serum hsCRP concentration in women with severe pre-eclampsia (PE).
Blood samples were collected from 25 pregnant women with severe PE and 202 healthy pregnant women who were divided into 4 groups by pregnancy duration. Levels of hsCRP were determined by the immunonephelometric method. Mean arterial pressure, time between delivery and diuresis, and mean ratio of systolic to diastolic blood flow velocity in uterine arteries were used as indicators of the severity of PE.
The median values of hsCRP in each group were 0.76 mg/L (0.16-13.61 mg/L), 1.53 mg/L (0.39-20.31 mg/L), 2.08 mg/L (0.50-9.45 mg/L), and 2.28 mg/L (0.44-8.11 mg/L) and showed a trend toward increase. Serum levels of hsCRP were positively correlated with each severity indicator of PE.
This study showed that hsCRP levels were positively correlated to pregnancy duration in healthy women and could be used as a severity marker in women with severe PE.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To investigate the values of C-reactive protein (CRP) in early pregnancy for detection of any abnormality of the conceptus and especially the condition of extra-uterine pregnancy (EUP). Study design In this prospective observational study, we established reference values for CRP in early pregnancy. Next, we tested whether a single, wide-range CRP measurement could serve as a diagnostic tool for abnormal first trimester pregnancy by comparing CRP levels in three different pregnancy statuses: viable intrauterine pregnancy (Group A), EUP (Group B) and delayed abortion (Group C). Results CRP levels were significantly higher in normal pregnancy (Group A) compared to abnormal pregnancy (Group B + C and Group B alone). CRP level was influenced only by the pregnancy status (normal, EUP or delayed abortion) and not by age, BMI, hematocrit or gravidity. The multiple logistic regression model (adjusted for age, gravidity, gestational age, hematocrit and BMI) revealed CRP as being a predictor for normal intrauterine pregnancy. Conclusion This study examined the association between CRP levels and abnormal first trimester pregnancies. Our results support single CRP measurement as a diagnostic tool in early pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology 05/2014; DOI:10.1016/j.ejogrb.2014.03.004 · 1.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Context: Polycystic ovary syndrome (PCOS) and pregnancy are conditions characterized by an increased low-grade chronic inflammation state. A higher incidence of pregnancy complications has been detected in pregnant PCOS women. Objective: The objective of the study was to test the hypothesis that the low-grade chronic inflammation state typical of PCOS patients persists during gestation and is exacerbated by pregnancy and contributes to the increased risk of obstetric/neonatal complications. Design: This was a prospective controlled clinical study. Setting: The study was conducted at the Academic Department of Obstetrics and Gynecology of the "Pugliese-Ciaccio" Hospital of Catanzaro (Catanzaro, Italy). Patients: One hundred fifty pregnant PCOS women and 150 age- and body mass index-matched healthy pregnant controls participated in the study. Interventions: Interventions included serial clinical, biochemical, and ultrasonographic assessments before and throughout pregnancy. Main Outcome Measures: Serum levels of white blood cell count (WBC), C-reactive protein (CRP), and ferritin were measured. Results: Pregnant women with PCOS had higher WBC, CRP, and ferritin levels at study entry and at all gestational ages than controls. Changes in serum WBC and ferritin levels were significantly higher in PCOS than in controls starting from the 12th week of gestation whereas those in CRP from the 20th week of gestation. By multivariable Cox proportional hazard analysis, in the PCOS group, a significant association with the risk of adverse obstetric/neonatal outcomes was found for WBC [hazard risk (HR) 1.52, 95% confidence interval (CI) 1.31-1.64; P = .010], CRP (HR 1.19, 95% CI 1.06-1.34; P = .019), and ferritin levels (HR 1.12, 95% CI 1.03-1.26; P = .011). Conclusions: In PCOS patients, the low-grade chronic inflammation persists during gestation and is exacerbated by pregnancy, and it is associated with adverse pregnancy outcomes.
    Journal of Clinical Endocrinology &amp Metabolism 05/2014; DOI:10.1210/jc.2014-1214 · 6.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective To compare concentrations of C-reactive protein in patients with preeclampsia and healthy normotensive pregnant women. Method We selected 70 patients. Thirty-five patients with preeclampsia were selected as cases (group A) and 35 healthy normotensive women with the same age and body mass index as those in group A were selected as controls (group B). Blood samples were collected in all patients before labor and immediately after diagnosis in group B to determine C-reactive protein concentrations. Results C-reactive protein concentrations differed significantly between patients in the study group (group A: 6.1 ± 2.2 mg/l) and those in the control group (group B: 3.5 ± 0.8 mg/l; P<.05). There was a weak, positive and significant correlation with values of systolic blood pressure (r=.314; P<.05) and diastolic blood pressure (r=.266; P<.05). A cutoff value of 180 pg/ml had an area under the curve of 0.86, a sensitivity of 76.3%, specificity of 81.2%, positive predictive value of 82.8%, and a negative predictive value of 74.2%. Conclusions C-reactive protein concentrations were significantly higher in patients with preeclampsia than in healthy normotensive pregnant women.
    Clínica e Investigación en Ginecología y Obstetricia 07/2014; DOI:10.1016/j.gine.2014.04.006